Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X1RQ
|
||||
Former ID |
DNCL001790
|
||||
Drug Name |
MTR105
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hypotension [ICD9: 458, 796.3; ICD10:I95] | Phase 2 | [522040] | ||
Company |
Meditor Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C7H19N2O4PS
|
||||
Canonical SMILES |
CCOP(=O)(O)OCC.CCSC(=N)N
|
||||
InChI |
1S/C4H11O4P.C3H8N2S/c1-3-7-9(5,6)8-4-2;1-2-6-3(4)5/h3-4H2,1-2H3,(H,5,6);2H2,1H3,(H3,4,5)
|
||||
InChIKey |
CSYSULGPHGCBQD-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Nitric-oxide synthase, endothelial | Target Info | Inhibitor | [529438] | |
BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
NetPath Pathway | Wnt Signaling Pathway | ||||
Pathway Interaction Database | Plasma membrane estrogen receptor signaling | ||||
Validated transcriptional targets of AP1 family members Fra1 and Fra2 | |||||
Angiopoietin receptor Tie2-mediated signaling | |||||
Thromboxane A2 receptor signaling | |||||
SHP2 signaling | |||||
VEGFR1 specific signals | |||||
Signaling events mediated by VEGFR1 and VEGFR2 | |||||
PAR1-mediated thrombin signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.